Nuclear Medicine and Biology
Volume 35, Issue 6 , Pages 697-705 , August 2008

N3-Substituted thymidine analogues V: Synthesis and preliminary PET imaging of N3-[18F]fluoroethyl thymidine and N3-[18F]fluoropropyl thymidine

Received 4 December 2007 ,Revised 18 March 2008 ,Accepted 25 March 2008.

References 

  1. Sun H, Sloan A, Mangner TJ, Vaishampayan U, Muzik O, Collins JM, et al. Imaging DNA synthesis with [18F]FMAU and positron emission tomography in patients with cancer. Eur J Nucl Med Mol Imaging. 2005;32:15–22
  2. Sun H, Mangner TJ, Collins JM, Muzik O, Douglas K, Shields AF. Imaging DNA synthesis in vivo with [18F]FMAU and PET. J Nucl Med. 2005;46:292–296
  3. Tehrani OS, Muzik O, Heilbrun LK, Douglas KA, Lawhorn-Crews JM, Sun H, et al. Tumor imaging using 1-(2′-deoxy-2′-fluoro-1-β-d-arabinofuranosyl)thymidine and PET. J Nucl Med. 2007;48:1436–1441
  4. Sugiyama M, Sakahara H, Sato K, Harada N, Jukumoto D, Kakiuchi T, et al. Evaluation of 3′-deoxy-3′-18F-fluorothymidine for monitoring tumor response to radiotherapy and photodynamic therapy in mice. J Nucl Med. 2004;45:1754–1758
  5. Grierson J, Shields AF. Radiosynthesis of 3′-deoxy-3′-[18F]fluorothymidine: [18F]FLT for imaging of cellular proliferation in vivo. Nucl Med Biol. 2000;27:143–156
  6. Alauddin MM, Conti PS, Fissekis JD. Synthesis of [18F]-labeled 2′-deoxy-2′-fluoro-1-β-d-arabinofuranosyluracil ([18F]FMAU). J Labelled Compd Radiopharm. 2002;45:583–590
  7. Mukhopadhyay U, Pal A, Gelovani JG, Bornmann W, Alauddin MM. Radiosynthesis of 2′-deoxy-2′-[18F]-fluoro-5-methyl-1-β-l-arabinofuranosyluracil ([18F]-L-FMAU) for PET. Appl Radiat Isot. 2007;65:941–946
  8. Mangner TJ, Klecker RW, Anderson L, Shields AF. Synthesis of 2′-deoxy-2′-[18F]fluoro-1-β-d-arabinofuranosyl nucleosides, [18F]FAU, [18F]FMAU, [18F]FBAU and [18F]FIAU, as potential PET agents for imaging cellular proliferation. Nucl Med Biol. 2003;30:215–224
  9. Alauddin MM, Conti PS, Fissekis JD. A general synthesis of [18F]-labeled 2′-deoxy-2′-fluoro-1-β-d-arabinofuranosyluracil nucleosides. J Labelled Compd Radiopharm. 2003;46:285–289
  10. Alauddin MM, Shahinian A, Park R, Tohme M, Fissekis JD, Conti PS. Synthesis of 2′-deoxy-2′-[18F]fluoro-5-bromo-1-β-d-arabino-furanosyluracil ([18F]FBAU) and 2′-deoxy-2′-[18F]fluoro-5-chloro-1-β-d-arabinofuranosyluracil ([18F]FCAU), and their biological evaluation as markers for gene expression. Nucl Med Biol. 2004;31:399–405
  11. Alauddin MM, Shahinian A, Gordon EM, Conti PS. Direct comparison of radiolabeled probes FMAU, FHBG and FHPG as PET imaging agents for HSV1-tk gene expression in human breast cancer model. Mol Imaging. 2004;3:76–84
  12. Alauddin MM, Shahinian A, Park R, Tohme M, Fissekis JD, Conti PS. Synthesis and evaluation of [18F]-FFAU as a potential PET imaging agent for gene expression. J Nucl Med. 2004;45:2063–2069
  13. Alauddin MM, Shahinian A, Gordon EM, Conti PS. Evaluation of 2′-deoxy-2′-fluoro-5-methyl-1-β-d-arabinofuranosyluracil (FMAU) as a potential gene imaging agent for HSV-tk expression in vivo. Mol Imaging. 2002;1:74–81
  14. Watanabe KA, Richmond W, Hirota K, Lopez C, Fox JJ. Nucleosides 110. Synthesis and herpes virus activity of some 2′-fluoro-2′-deoxyarabinofuranosyl pyrimidine nucleosides. J Med Chem. 1979;22:21–24
  15. Watanabe KA, Su TL, Reichman U, Greenberg N, Lopez C, Fox JJ. Nucleosides 129. Synthesis of antiviral nucleosides: 5-Alkenyl 1-(2-deoxy-2-fluoro-β-d-arabinofuranosyl)-uracils. J Med Chem. 1984;27:91–94
  16. Perlman ME, Watanabe KA, Schinazi RF, Fox JJ. Synthesis of 5-alkenyl-1-(2-deoxy-2-fluoro-β-d-arabinofuranosyl)cytosines and related pyrimidine nucleosides as potential antiviral agents. J Med Chem. 1985;28:741–748
  17. Tann CH, Brodfuehrer PR, Brundidge SP, Sapino C, Howell HG. Fluorocarbohydrates in synthesis. An efficient synthesis of 1-(2-deoxy-2-fluoro-β-d-arabinofuranosyl)-5-iodouracil (β-FIAU) and 1-(2-deoxy-2-fluoro-β-d-arabinofuranosyl)thymine (β-FMAU). J Org Chem. 1985;50:3644–3647
  18. Fox JJ, Watanabe KA, Chou TC, Schinazi RF, Soike KF, Fourel I, et al. In:  Taylor NF editors. Fluorinated Carbohydrates. Washington, DC: Am Chem Soc; 1998;p. 176–190[Chapter 10]
  19. Horn DM, Neeb LA, Colacino JM, Richardson FC. Fialuridine is phosphorylated and inhibits DNA synthesis in isolated rat hepatic mitochondria. Antiviral Res. 1997;34:71–74
  20. Colacino JM. Mechanisms for the anti-hepatitis B virus activity and mitochondrial toxicity of fialuridine (FIAU). Antiviral Res. 1996;29:125–139
  21. Conti PS, Alauddin MM, Fissekis JD, Schmall B, Watanabe KA. Synthesis of 2′-fluoro-5-[11C]methyl-1-β-d-arabinofuranosyluracil ([11C]-FMAU): a potential nucleoside analogue for in vivo study of cellular proliferation with PET. Nucl Med Biol. 1995;22:783–789
  22. Conti PS, Bading JR, Alauddin MM, Fissekis JD, Berenji B. Preliminary clinical imaging trials with the tumor imaging 2′-fluoro-5-[11C]-methyl-1-β-d-arabinofuranosyluracil (11C-FMAU). Comparison studies with FDG. RSNA. 2002;Chicago (Ill)
  23. Mercer J, Knaus EE, Weibe LI. Synthesis and tumor uptake of 5-halo-1-(2′-fluoro-2′-deoxy-beta-d-ribofuranosyl)[2-14C]uracils. J Med Chem. 1987;30:670–675
  24. Shields AF, Grierson JR, Kazawa SM, Zheng M. Development of labeled thymidine analogs for imaging tumor proliferation. Nucl Med Biol. 1996;23:17–22
  25. Alauddin MM, Balatoni J, Gelovani J. Radiosynthesis of 3′-deoxy-3′-[18F]-fluoro-1-β-d-xylo-furanosyluracil ([18F]-FMXU) for PET. J Labelled Compd Radiopharm. 2005;48:941–950
  26. Buck AK, Halter G, Schirrmeister H, Kotzerke J, Wuriger I, Glatting G, et al. Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG. J Nucl Med. 2003;44:1426–1431
  27. Bading JR, Shahinian A, Bathija P, Conti PS. Pharmacokinetics of the thymidine analog 2′-fluoro-5-[14C]-methyl-1-β-d-arabinofuranosyluracil ([14C]FMAU in rat prostate tumor cells. Nucl Med Biol. 2000;27:361–368
  28. Lunato AJ, Wang J, Woollard JE, Anisuzzaman AKM, Ji W, Rong FG, et al. Synthesis of 5-(carboranylalkylmercapto)-2′-deoxyuridines and 3-(carboranylalkyl)-thymidines and their evaluation as substrates for human thymidine kinase. J Med Chem. 1999;42:3373–3389
  29. Byun Y, Yan J, Al-Madhoun AS, Johnsamuel J, Yang W, Barth RF, et al. The synthesis and biological evaluation of thymidine analogues substituted with nido and carborane at the N-3 position. Appl Radiat Isot. 2004;61:1125–1130
  30. Byun Y, Yan J, Al-Madhoun AS, Johnsamuel J, Yang W, Barth RF, et al. Synthesis and biological evaluation of neutral and zwitterionic 3-carboranyl thymidine analogues for boron neutron capture therapy. J Med Chem. 2005;48:1188–1198
  31. Al-Madhoun AS, Johnsamuel J, Yan J, Ji W, Wang J, Zhou J, et al. Synthesis of a small library of 3-(carboranylalkyl)thymidines and their biological evaluation as substrates for human thymidine kinases 1 and 2. J Med Chem. 2002;45:4018–4028
  32. Al-Madhoun AS, Johnsamuel J, Barth RF, Tjarks W, Eriksson S. Evaluation of human thymidine kinase 1 substrates as new candidates for boron neutron capture therapy. Cancer Res. 2004;64:6280–6286
  33. Bandyopadhyaya AK, Johnsamuel J, Al-Madhoun AS, Erikson S, Tjarks W. Comparative molecular field analysis and comparative molecular similarity indices analysis of human thymidine kinase 1 substrates. Bioorg Med Chem. 2005;13:1681–1689
  34. Alauddin MM, Ghosh P, Gelovani J. Synthesis of [18F]-labeled N3-substituted thymidine analogues: N-3([18F]fluorobutyl) thymidine ([18F]-FBT) and N-3([18F]fluoropentyl) thymidine ([18F]-FPT) for PET. J Labelled Compd Radiopharm. 2006;49:1079–1088
  35. Ghosh P, Gelovani J, Alauddin MM. N3-Substituted thymidine analogues: III. Radiosynthesis of N3-[(4-[18F]fluoromethyl-phenyl)butyl]thymidine ([18F]-FMPBT) and N3-[(4-[18F]fluoromethyl-phenyl)pentyl] thymidine ([18F]-FMPPT) for PET. J Labelled Compd Radiopharm. 2007;50:1185–1195
  36. Toyohara J, Hayashi A, Gogami A, Hamada M, Hamashima Y, Katoh T, et al. Alkyl-fluorinated thymidine derivatives for imaging cell proliferation: I. The in vitro evaluation of some alkyl-fluorinated thymidine derivatives. Nucl Med Biol. 2006;33:751–764
  37. Toyohara J, Hayashi A, Gogami A, Fujibayashi Y. Alkyl-fluorinated thymidine derivatives for imaging cell proliferation: II. Synthesis and evaluation of N3-(2-[18F]fluoroethyl)-thymidine. Nucl Med Biol. 2006;33:765–772
  38. Balzarini J, Celen S, Karlsson A, de Groot T, Verbruggen A, Bormans G. The effect of a methyl or 2-fluoroethyl substitution at the N-3 position of thymidine, 3′-fluoro-3′-deoxythymidine and 1-beta-d-arabinosylthymdine on their antiviral and cytostatic activity in cell culture. Antivir Chem Chemother. 2006;17:17–23
  39. Alauddin MM, Conti PS. Selective alkylation of pyrimidyl dianion: synthesis, characterization and comparative reactivity of 3′,5′-O-bis-tetrahydropyranyl, trimethylsilyl and t-butyldimethylsilyl derivatives of 5-bromo-2′-deoxyuridine. Tetrahedron. 1994;50:1699–1706
  40. Nishii R, Volgin AY, Mawlawi O, Mukhopadhyay U, Pal A, Bornmann W, et al. Evaluation of 2′-deoxy-2′-[18F]fluoro-5-methyl-1-β-l-arabinofuranosyluracil ([18F]-l-FMAU) as a PET imaging agent for cellular proliferation: Comparison with [18F]-d-FMAU and [18F]FLT. Eur J Nucl Med Mol Imaging. 2007;35:990–998
  41. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab. 1983;3:1–7

PII: S0969-8051(08)00081-4

doi: 10.1016/j.nucmedbio.2008.03.007

Nuclear Medicine and Biology
Volume 35, Issue 6 , Pages 697-705 , August 2008

Article Tools

* Image Usage & Resolution